The National Eye Institute estimates that 50 million Americans will be blind, have low vision, or an age-related eye disease by 2020 unless appropriate treatments and therapies are employed. Investing in eye and vision research now can reduce the prevalence of visual impairment among Americans and the costs associated with treating and caring for them.
New Ways to Diagnose and Treat Vision Impairment
Physicians and scientists at the Eye Institute are committed to investigating new and better ways to diagnose and treat vision impairment. Eye Institute doctors and surgeons are participating in 37 national clinical trials for new drugs, surgeries and treatments. The Eye Institute also has two complete floors of laboratories where scientists work to uncover the “hows” and “whys” of disease in order to move more effective treatments into the clinics. This two-pronged approach affords our patients with therapies that are based on rigorous scientific examination and have been thoroughly evaluated and tested by some of the top physicians in the country.
In recognition of our commitment to advancing vision and saving sight, the Eye Institute receives major funding from Research to Prevent Blindness (RPB) and the National Eye Institute (NEI). In fact, the Froedtert & the Medical College Eye Institute is one of a limited number of institutions nationwide that receive a "Core Grant for Vision Research" from the NEI.
Improved treatments and earlier diagnosis of disease can change lives, restore independence and ease suffering. We know that sight is a precious gift and our patients are given the best care possible in order to preserve their vision.